Article Details
Retrieved on: 2024-04-23 19:49:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Recently listed Alto Neuroscience Inc (NYSE:ANRO) released results from its healthy volunteer Phase 1 study of ALTO-101, a novel PDE4 in...
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here